2015. ISOQOL Annual Conference – Health-Related Quality of Life in CLARINET, a phase III Trial of Lanreotide Autogel 120 mg in Patients with Non-Functioning Entero-Pancreatic neuroendocrine Tumour: Analytical Challenges and Statistical Solutions

Regnault A, Ferrer L, Dinet J, Gabriel S, Pavel ME, Ruszniewski, PB, Caplin ME. Health-Related Quality of Life in CLARINET, a phase III Trial of Lanreotide Autogel 120 mg in Patients with Non-Functioning Entero-Pancreatic neuroendocrine Tumour: Analytical Challenges and Statistical Solutions. Qual Life Res. 2015; 24:75. Abstract Number 1001. Presented at: ISOQOL 22nd Annual Conference; October 22, 2015; Vancouver, Canada.